Jørgen Skov Jensen mainly focuses on Mycoplasma genitalium, Urethritis, Virology, Azithromycin and Internal medicine. Jørgen Skov Jensen interconnects Mycoplasmataceae, Sexually transmitted disease and Microbiology in the investigation of issues within Mycoplasma genitalium. His study looks at the relationship between Sexually transmitted disease and fields such as Gynecology, as well as how they intersect with chemical problems.
His study looks at the relationship between Urethritis and topics such as Cervicitis, which overlap with Pelvic inflammatory disease. His Virology research includes themes of Typing, Pcr assay, Polymerase chain reaction and Antibiotic resistance. His work carried out in the field of Azithromycin brings together such families of science as Moxifloxacin, Antibacterial agent, Doxycycline and Drug resistance.
Jørgen Skov Jensen mostly deals with Mycoplasma genitalium, Microbiology, Virology, Urethritis and Internal medicine. His Mycoplasma genitalium study incorporates themes from Moxifloxacin, Antibiotic resistance, Azithromycin and Cervicitis. His biological study spans a wide range of topics, including Doxycycline and Drug resistance.
His study looks at the intersection of Virology and topics like Polymerase chain reaction with Molecular biology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Chlamydia, Immunology and Gynecology. His Chlamydia trachomatis research includes elements of Trichomonas vaginalis, Ureaplasma urealyticum and Sexually transmitted disease.
Jørgen Skov Jensen mainly investigates Mycoplasma genitalium, Azithromycin, Antibiotic resistance, Moxifloxacin and Urethritis. His Mycoplasma genitalium research is multidisciplinary, incorporating perspectives in Internal medicine and Antimicrobial, Microbiology. Jørgen Skov Jensen combines subjects such as Chlamydia trachomatis and Doxycycline with his study of Azithromycin.
Jørgen Skov Jensen has included themes like Transmission, Epidemiology and Neisseria gonorrhoeae in his Antibiotic resistance study. The study incorporates disciplines such as Pristinamycin, Pelvic inflammatory disease, Sitafloxacin, Combination therapy and Drug resistance in addition to Moxifloxacin. His work deals with themes such as MEDLINE, Cervicitis, Asymptomatic, Ureaplasma and Etiology, which intersect with Urethritis.
His primary areas of investigation include Mycoplasma genitalium, Antibiotic resistance, Moxifloxacin, Microbiology and Internal medicine. His Mycoplasma genitalium study combines topics from a wide range of disciplines, such as Antibiotics, Azithromycin, Multiplex and Drug resistance. His Antibiotic resistance research incorporates themes from Antimicrobial, Etest, Whole genome sequencing and Virology.
While the research belongs to areas of Moxifloxacin, Jørgen Skov Jensen spends his time largely on the problem of Pelvic inflammatory disease, intersecting his research to questions surrounding Pelvis, Adverse effect, Salpingitis and Pristinamycin. His work investigates the relationship between Microbiology and topics such as In vitro that intersect with problems in Drug and Polymerase chain reaction. Urethritis is the focus of his Internal medicine research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly
David Taylor-Robinson;Jørgen Skov Jensen.
Clinical Microbiology Reviews (2011)
Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic.
Jørgen Skov Jensen;Eva Björnelius;Birthe Dohn;Peter Lidbrink.
Journal of Clinical Microbiology (2004)
Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples.
J S Jensen;S A Uldum;J Søndergård-Andersen;J Vuust.
Journal of Clinical Microbiology (1991)
Binding of ATP to brain microsomal ATPase. Determination of the ATP-binding capacity and the dissociation constant of the enzyme-ATP complex as a function of K+ concentration.
Jens G. Nørby;Jørgen Jensen.
Biochimica et Biophysica Acta (1971)
Azithromycin Treatment Failure in Mycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance
Jørgen S. Jensen;Catriona S. Bradshaw;Catriona S. Bradshaw;Sepehr N. Tabrizi;Sepehr N. Tabrizi;Christopher K. Fairley;Christopher K. Fairley.
Clinical Infectious Diseases (2008)
2016 European guideline on Mycoplasma genitalium infections
J.S. Jensen;M. Cusini;M. Gomberg;H. Moi.
Journal of The European Academy of Dermatology and Venereology (2016)
Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection
Lars Falk;Hans Fredlund;J. S. Jensen.
Sexually Transmitted Infections (2005)
Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases
Jørgen Skov Jensen.
Journal of The European Academy of Dermatology and Venereology (2004)
Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome
T. Benfield;J. S. Jensen;B. G. Nordestgaard.
Diabetologia (2007)
Mycoplasma genitalium: prevalence, clinical significance, and transmission
C Anagrius;B Loré;J S Jensen.
Sexually Transmitted Infections (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Örebro University
Monash University
University of Melbourne
Monash University
Imperial College London
University of Melbourne
University of Copenhagen
Aarhus University Hospital
University of Bern
Copenhagen University Hospital
École Polytechnique Fédérale de Lausanne
National Centre of Scientific Research Demokritos
Norwegian University of Science and Technology
IBM (United States)
University of Lorraine
Leiden University
Tel Aviv University
University of Auckland
Ionis Pharmaceuticals (United States)
Finnish Environment Institute
University of Leeds
Imperial College London
National University of Singapore
University of Michigan–Ann Arbor
Keio University
University of California, Berkeley